PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy.\', \'ASST Lecco, MS Center, Lecco, Italy.\', \'San Raffaele Hospital IRCCS, Multiple sclerosis center-Neurology Department, Milano, Italy.\', \'Grande Ospedale Metropolitano Bianchi Melacrino Morelli, UOC Neurologia, Reggio Calabria, Italy.\', \'San Paolo Hospital ASL Napoli 1 Centro, Neurology Unit and MS Center, Napoli, Italy.\', \'IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy.\', \'IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy; University of Rome Tor Vergata, Department of Systems Medicine, Roma, Italy.\', \'University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy; IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(21)00612-X10.1016/j.msard.2021.103345
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 35158454
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35158454>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35158454>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all